Blog

Artificial intelligence (AI) has firmly established itself within life sciences, catalysing breakthroughs in drug discovery, diagnostics, and data analysis.

The life sciences industry stands on the threshold of significant progress in 2025, driven by advancements in technology, regulatory adaptation, and an increasing commitment to sustainability.

Operational Technology (OT) and Information Technology (IT) were once distinct domains within industries, each with its own scope and priorities. OT focused on controlling and monitoring physical systems, while IT managed data and digital operations.

The worlds of Operational Technology (OT) and Information Technology (IT) have traditionally functioned independently, but in recent years, the boundaries between these two domains have begun to blur.

The life sciences industry has always been at the forefront of innovation, and with rapid technological advancements, it now relies heavily on robust IT infrastructure to support groundbreaking research and development.

The value of the global life sciences market stood at $2.83 trillion in 2023 thanks largely to technological advancements in customised healthcare, biotechnology, pharmaceuticals and genetics.